GSK (LON:GSK) Reaches New 12-Month High at $1,767.50

Shares of GSK plc (LON:GSK) hit a new 52-week high during trading on Wednesday . The company traded as high as GBX 1,767.50 ($22.20) and last traded at GBX 1,762.54 ($22.14), with a volume of 15331153 shares trading hands. The stock had previously closed at GBX 1,733.50 ($21.78).

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 1,950 ($24.50) price objective on shares of GSK in a research note on Wednesday, April 17th. Shore Capital reaffirmed a “buy” rating on shares of GSK in a research report on Wednesday, May 1st. Barclays reaffirmed an “equal weight” rating and set a GBX 1,725 ($21.67) target price on shares of GSK in a report on Tuesday. JPMorgan Chase & Co. lifted their price target on GSK from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) and gave the stock an “underweight” rating in a report on Thursday, May 2nd. Finally, Berenberg Bank lifted their target price on GSK from GBX 1,650 ($20.73) to GBX 1,820 ($22.86) and gave the stock a “buy” rating in a report on Wednesday, February 14th. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, GSK has an average rating of “Hold” and a consensus target price of GBX 1,675.63 ($21.05).

GSK Trading Up 0.7 %

The company has a debt-to-equity ratio of 140.82, a current ratio of 0.88 and a quick ratio of 0.73. The firm has a market cap of £72.54 billion, a price-to-earnings ratio of 1,468.79, a price-to-earnings-growth ratio of 1.12 and a beta of 0.27. The firm’s fifty day moving average is GBX 1,666.29 and its 200-day moving average is GBX 1,562.88.

GSK Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, July 11th. Investors of record on Thursday, May 16th will be given a dividend of GBX 15 ($0.19) per share. The ex-dividend date is Thursday, May 16th. This represents a dividend yield of 0.9%. GSK’s payout ratio is 5,333.33%.

Insider Buying and Selling

In other GSK news, insider Urs Rohner purchased 434 shares of the company’s stock in a transaction on Wednesday, March 20th. The shares were purchased at an average cost of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,061.66). In other news, insider Urs Rohner bought 434 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was acquired at an average cost of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,061.66). Also, insider Emma Walmsley sold 139,792 shares of the stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of GBX 1,658 ($20.83), for a total value of £2,317,751.36 ($2,911,747.94). 1.77% of the stock is currently owned by insiders.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.